| name | es-ghc-hypoglycemia-safeguards |
| description | This skill guides clinicians to apply safeguards—including frequent point-of-care glucose monitoring and insulin dose adjustments—to prevent hypoglycemia when tapering or discontinuing glucocorticoids in hospitalized patients. Use when encountering triggers such as "Glucocorticoid being tapered, how to avoid hypoglycemia?" or "Stopping steroids, need to avoid low blood sugar." |
Apply safeguards to avoid hypoglycemia when tapering or discontinuing glucocorticoids
STEP 1 — Gather Information
Collect current glucocorticoid type, dose, frequency, and taper plan; recent point-of-care glucose values; current insulin regimen (NPH-based or basal bolus); history of hypoglycemia; renal function.
STEP 2 — Rule In / Rule Out
Rule in: hyperglycemia (point-of-care glucose >140 mg/dL) while receiving glucocorticoids. Rule out: normoglycemia or patient not on glucocorticoids.
STEP 3 — Classify or Stratify
Classify glucocorticoid timing and duration to match insulin regimen: morning-only GC → once-daily NPH; twice-daily GC → divided NPH doses; continuous or stress-dose GC → consider basal bolus insulin.
STEP 4 — Decide
Initiate selected insulin regimen with ongoing glucose monitoring (e.g., every 4–6 hours) and preemptively reduce insulin dose as glucocorticoid taper progresses to avoid hypoglycemia.
Clinical Guardrails / Mimics / Pitfalls
Do not abruptly stop insulin without monitoring; avoid sliding-scale-only therapy; do not fail to adjust insulin as glucocorticoid dose decreases; do not ignore hypoglycemia symptoms; avoid NPH dosing that does not align with glucocorticoid pharmacokinetics.
Concrete Clinical Example
A 68‑year‑old on prednisone 40 mg daily for COPD exacerbation develops hyperglycemia (glucose 180 mg/dL). Started on NPH 10 units each morning. Prednisone tapered by 10 mg every 48 hours; glucose checked q6h and NPH reduced by 2 units with each taper step; no hypoglycemia occurred.
Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278
